TIZANIDINE
Generic: TIZANIDINE
TIZANIDINE is FDA application ANDA211798, sponsored by ALKEM LABS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tabl
Failed Tablet/Capsule Specification: Some tablets are shaved
Failed dissolution specification: Out of specification results observed in 24-month long term stabil
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the
Failed Dissolution Specifications; Out of Specification (low) results were obtained.
Failed Stability Specifications
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
Failed Dissolution Specifications: this repackaged product was recalled by the manufacturer, Dr. Red